Pharmacological options in the management of orthostatic hypotension in older adults

Expert Review of Cardiovascular Therapy

Volumn 7, Issue 11, 2009, Pages 1395-1400

  Kearney, Fiona ^a   Moore, Alan ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Blood pressure monitoring; Fludrocortisone; Midodrine; Older adults; Orthostatic hypotension

Indexed keywords

CLONIDINE; DESMOPRESSIN; DIHYDROERGOTAMINE; EPHEDRINE; ERYTHROPOIETIN; FLUDROCORTISONE; HYPERTENSIVE AGENT; MIDODRINE; OCTREOTIDE; PLACEBO; POTASSIUM; THREO 3,4 DIHYDROXYPHENYLSERINE; VASOPRESSIN DERIVATIVE; YOHIMBINE;

ABDOMINAL CRAMP; ANEMIA; BLOOD BRAIN BARRIER; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD VOLUME; BRADYCARDIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COMPRESSION GARMENT; CONGESTIVE HEART FAILURE; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG METABOLISM; DRUG PENETRATION; EVENING DOSAGE; EVIDENCE BASED MEDICINE; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LIFESTYLE MODIFICATION; NONHUMAN; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHOTOELECTRIC PLETHYSMOGRAPHY; QT PROLONGATION; REVIEW; SALT INTAKE; SEIZURE; SIDE EFFECT; SODIUM BLOOD LEVEL; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA; TILT TABLE TEST; URINE RETENTION; VASODILATATION; WATER INTOXICATION;

ADRENERGIC ALPHA-AGONISTS; ANTI-INFLAMMATORY AGENTS; DRUG THERAPY, COMBINATION; FLUDROCORTISONE; HUMANS; HYPOTENSION, ORTHOSTATIC; MIDODRINE;

EID: 73349099723     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.130     Document Type: Review

References (36)

1. Tilvis RS, Hakala S-M, Valvanne J, Erkinjuntti T. Postural hypotension and dizziness in a general aged population: a four year follow up of the Helsinki Aging study. J. Am. Geriatr. Soc. 44, 809-814 (1996).
2. Raiha I, Luutonen S, Piha J, Seppanen A, Toikka T, Sourander L. Prevalence, predisposing factors and prognostic importance of postural hypotension. Arch. Intern. Med. 155, 930-935 (1995).
3. Tinetti ME, Williams TF. Fall risk index for elderly patients based on number of chronic disabilities. Am. J. Med. 80, 429-434 (1986). • Highlights the multiple factors involved in assessing older patients with falls and syncope.
4. Macrae AD, Bulpitt CJ. Assessment of postural hypotension in elderly patients. Age Ageing 9, 17-24 (1989). • Highlights the key need to standardize timing of postural assessment.
5. Bannister R, Mathias C. Investigation of Autonomic Disorders. In: Autonomic Failure, A Textbook of Clinical Disorders of the Autonomic Nervous System. 3rd Edition. Oxford University Press, Oxford, UK, 260-262 (2001). •• Outlines the principle pathophysiology and provocative tests for appropriate assessment of autonomic disorders, including orthostatic hypotension.
6. Kenny RA, Bayliss J, Ingram A, Sutton R. Head-up tilt table testing: a useful test for investigating unexplained falls. Lancet 1352-1354 (1986).
7. Kearney F, Moore A, Donegan C. Orthostatic hypotension in older adults. Rev. Clin. Gerontol. 17(4), 259-275 (2007). •• Details the pathophysiology, assessment and treatment of older adults with orthostatic hypotension; also highlights the role of certain drug classes in exacerbating symptoms of orthostatic hypotension.
8. Hickman JB, Pryor WW. Cardiac output in postural hypotension. J Clin Invest 30, 401-405 (1951)
9. Bevegard BS, Jonsson B, Karlof I. Circulatory responses to recumbent exercise and head up tilting in patients with disturbed sympathetic control. (postural hypotension). Observations on the effect of norepinephrine infusion and anti-gravity suit inflation in the head up tilt position. Acta Med Scand 172, 623-636 (1962).
10. Jacob G, Robertson D, Mosqueda-Garcia R, Ertl AC, Robertson RM, Biaggoni I. Hypovolaemia in syncope and orthostatic intolerance: role of the renin-angiotensin system. Am. J. Med. 103, 128-133 (1997).
11. Low PA, Gilden JL, Freeman R, Sheng K-N, McElligott MA. Efficacy of midodrine vs. placebo in neurogenic orthostatic hypotension: a randomised double blind multi-centre study. JAMA 277, 1046-1051 (1997). •• Largest randomized, placebo-controlled trial of midodrine in the treatment of orthostatic hypotension.
12. Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen W-K, Schondorf R, Suarez GA, Rummans TA. The grading of orthostatic intolerance and orthostatic Grade by Tilt Up. Neurology (Suppl. 5), S19-S25 (1995).
13. Kearney F, Moore A. Treatment of combined hypertension and orthostatic hypotension in older adults: more questions than answers still remain. Expert Rev. Cardiovasc. Ther. 6, 557-560 (2009). • Addresses the difficult treatment dilemma posed by older patients, presenting with combined hypertension and orthostatic hypotension.
14. Mtinangi BL, Hainsworth R. Early effects of oral salt on plasma volume, orthostatic tolerance, and barorecptor sensitivity in patients with syncope. Clin. Auton. Res. 8, 231-235 (1998).
15. Oribe E, Kaufmann H, Winters S et al. Fludrocortisone versus beta-adrenergic blockers in the treatment of vasovagal syncope. Neurology (Suppl. 3), 213 (1992).
16. van Liieshout JJ, ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output autonomic failure. Clin. Auton. Res. 10(1), 35-42 (2000).
17. Davies IB, Bannister R, Sever PS et al. The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone. Br. J. Clin. Pharmacol. 8, 253-260 (1979).
18. Wieling W, van Lieshout JJ, Hainswoth R. Extracellular fluid volume expansion in patients with posturally related syncope. Clin. Auton. Res. 12, 242-249 (2002).
19. Chobanian AV Volicer L, Tifft Cp, Gavras H, liang CS, Faxon D. Mineralocorticoidinduced hypertension in patients with orthostatic hypotension. N. Engl. J. Med. 301, 68-73 (1979).
20. Ozawa T, Tanaka H, Nakano R et al. Nocturnal decrease in vasopressin secretion into plasma in patienys with multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 67, 542-545 (1999).
21. Mathias CJ, Foabraey P, da Costa DF, Thornley A, Bannister R. The effect of desmopresin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. BMJ (Clin. Res. Ed.) 293, 353-354 (1986).
22. Sakakibara R, Matsuda S, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. The effect of intranasal desmopressin on nocturnal waking in urination in multiple systems atrophy patients with nocturnal polyuria. Clin. Auton. Res. 13, 106-108 (2003).
23. Senard JM, Montastruc JL. Which drug for which orthostatic hypotension? Fundam. Clin. Pharmacol. 10, 225-233 (1996).
24. Robertson D, Goldberg MR, Hollister AS, Wade D, Robertson RM. Clonidine raises blood pressure in severe idiopathic hypotension. Am. J. Med. 74, 193-199 (1983).
25. Thulesius O, Giores JE, Berlin E. Vasoconstrictor effects of midodrine, ST 1059, noradrenaline, etilifrine and dihydroergotamine on isolated human veins Eur. J. Clin. Pharmacol. 16, 423-424 (1979). • Confirms the vasoconstricting effect of midodrine through its action on α- receptors.
26. Henry R, Rowe J, O'Mahony D. Haemodynamic analysis of efficacy of compression hosiery in elderly fallers with orthostatic hypotension. Lancet 354, 45-6 (1999).
27. Wright RA, Kaufmann HC, Perera R et al. A doule-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 51, 120-124 (1998).
28. Hoeldtke RD, Davis KM, Joseph J, Gonzales R, Panidis IP, Friedman AC. Haemodynamic effects of octreotide in patients with autonomic neuropathy. Circulation 84, 168-176(1991).
29. Almqvist A, Goldenberg IF, Milstein S et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N. Engl. J. Med. 320, 346-351 (1989).
30. Dusl RJ, Anderson DS, Forsythe AB et al. Treatment of diabetic diarrhoea and orthostatic hypotension with somatostatin analogue "SMS 201-295" Am. J. Med. 83, 584-588 (1987).
31. Bordet R, Benhadjali J, Liberesa L et al. Octreotide in Orthostatic hypotension in patients with Multiple System Atrophy. Clin. Neuropharmacol. 18, 83-89 (1995).
32. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs. Treatment of orthostatic hypotension with midodrine and octreotide. J. Clin. Endocrinol. Metab. 83, 339-343 (1998).
33. Mathias CJ. L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension. Clin. Auton. Res. 18(Suppl. 1), 25-29 (2008). • Details the recent European experience in the use of Droxidopa and its efficacy, tolerability and safety in patients with pure autonomic failure.
34. Jordan J, Shannon JR, Biaggioni I et al. Contrasting actions of pressor agents in severe autonomic failure. Am. J. Med. 105, 116-124 (1998).
35. Conte JJ, Fournie GJ, Maurette MH. Dihydroergotamine: an effective treatment for postural hypotension due to antihypertensive drugs (ganglion-blocking agents excepted). Cardiology 61(Suppl. 1), 334-341(1976).
36. Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N. Engl. J. Med. 329, 611-615 (1993).